Skip to main content
. 2022 Jul 8;8(7):717. doi: 10.3390/jof8070717

Table 2.

Percent mortality (Means ± SE) of immature stages of FAW treated with different concentrations of isolates of Beauveria bassiana.

Percent Mortality ± Means Standard Error
Concentrations Isolates Eggs A Neonates B Larvae C Pupae D
1 × 106 Conidia/mL C QB-3.45 A 30.0 ± 1.7 a 9.5 ± 0.3 ab 10.0 ± 1.0 a 6.7 ± 0.3 a
QB-3.46 AB 25.3 ± 1.2 a 13.4 ± 2.1 ab 8.9 ± 1.2 a 3.3 ± 0.3 a
QB-3.428 B 28.7 ± 1.8 a 14.9 ± 1.5 a 7.8 ± 0.9 a 3.3 ± 0.3 a
QB-3.436 C 20.7 ± 1.5 ab 13.4 ± 1.2 ab 7.8 ± 0.7 a 3.3 ± 0.3 a
LNSE-22 D 24.0 ± 1.5 a 9.6 ± 0.9 ab 4.4 ± 0.9 a 0.0 ± 0.0 a
SPLE-24 E 10.7 ± 0.9 bc 6.7 ± 1.2 ab 4.4 ± 0.3 a 3.3 ± 0.3 a
ZGNKY-01 E 11.3 ± 0.7 bc 4.5 ± 1.0 ab 1.1 ± 0.3 a 0.0 ± 0.0 a
ZGNKY-1 FG 4.0 ± 0.6 c 6.3 ± 0.6 ab 1.1 ± 0.3 a 0.0 ± 0.0 a
ZGNKY-2 G 5.3 ± 1.5 c 3.5 ± 0.3 ab 1.1 ± 0.3 a 0.0 ± 0.0 a
ZGNKY-3 G 2.0 ± 0.6 c 4.8 ± 0.9 ab 1.1 ± 0.3 a 0.0 ± 0.0 a
ZGNKY-4 EF 8.0 ± 1.5 c 2.2 ± 0.6 ab 2.2 ± 0.3 a 0.0 ± 0.0 a
ZGNKY-5 G 3.3 ± 0.9 c 1.4 ± 0.7 b 1.1 ± 0.3 a 0.0 ± 0.0 a
1 × 107 Conidia/mL B QB-3.45 A 87.3 ± 1.5 a 47.6 ± 1.2 ab 9.5 ± 0.3 a 10.0 ± 0.0 a
QB-3.46 AB 82.7 ± 2.4 a 53.6 ± 1.5 a 13.4 ± 2.1 ab 6.7 ± 0.3 a
QB-3.428 B 79.3 ± 2.2 a 45.3 ± 0.9 a 14.9 ± 1.5 abc 6.7 ± 0.3 a
QB-3.436 C 56.0 ± 2.3 b 34.8 ± 1.2 abc 13.4 ± 1.2 abc 6.7 ± 0.3 a
LNSE-22 D 50.0 ± 2.0 bc 30.7 ± 1.2 abcd 9.6 ± 0.9 abc 3.3 ± 0.3 a
SPLE-24 E 30.7 ± 0.3 def 20.2 ± 1.2 bcde 6.7 ± 1.2 bc 3.3 ± 0.3 a
ZGNKY-01 E 39.3 ± 2.2 bcd 17.6 ± 0.7 cde 4.5 ± 1.0 bc 3.3 ± 0.3 a
ZGNKY-1 FG 20.0 ± 2.3 efg 15.8 ± 1.2 cde 6.3 ± 0.6 c 3.3 ± 0.3 a
ZGNKY-2 G 12.7 ± 1.5 fg 12.2 ± 1.2 cde 3.5 ± 0.3 c 3.3 ± 0.3 a
ZGNKY-3 G 15.3 ± 1.5 fg 10.2 ± 1.5 de 4.8 ± 0.9 c 3.3 ± 0.3 a
ZGNKY-4 EF 35.3 ± 1.5 cde 10.3 ± 0.9 cde 2.2 ± 0.6 bc 3.3 ± 0.3 a
ZGNKY-5 G 18.7 ± 2.0 efg 8.2 ± 0.9 de 1.4 ± 0.7 c 3.3 ± 0.3 a
1 × 108 Conidia/mL A QB-3.45 A 70.0 ± 1.2 a 20.0 ± 0.6 abcd 25.6 ± 1.2 a 20.0 ± 0.6 a
QB-3.46 AB 64.7 ± 1.9 ab 34.6 ± 0.9 a 20.0 ± 1.0 ab 16.7 ± 0.7 ab
QB-3.428 B 54.7 ± 1.8 b 30.8 ± 1.5 a 17.8 ± 0.9 abc 13.3 ± 0.3 ab
QB-3.436 C 40.0 ± 2.3 c 25.6 ± 1.2 ab 14.4 ± 1.5 abcd 10.0 ± 0.0 ab
LNSE-22 D 35.3 ± 1.2 c 21.7 ± 0.6 abc 10.0 ± 1.0 bcd 6.7 ± 0.3 ab
SPLE-24 E 15.3 ± 1.2 de 12.6 ± 0.9 bcde 10.0 ± 1.0 bcd 6.7 ± 0.3 ab
ZGNKY-01 E 18.7 ± 0.9 d 10.6 ± 0.9 bcde 7.8 ± 0.3 bcd 3.3 ± 0.3 ab
ZGNKY-1 FG 10.0 ± 1.2 de 9.6 ± 0.9 cde 5.6 ± 0.3 cd 3.3 ± 0.3 ab
ZGNKY-2 G 6.7 ± 0.9 de 7.9 ± 1.2 cde 4.4 ± 0.3 cd 6.7 ± 0.3 ab
ZGNKY-3 G 8.0 ± 0.6 de 7.2 ± 0.7 cde 5.6 ± 0.7 cd 6.7 ± 0.3 ab
ZGNKY-4 EF 17.3 ± 2.3 d 5.6 ± 0.3 cde 12.2 ± 0.3 abcd 3.3 ± 0.3 ab
ZGNKY-5 G 8.7 ± 0.9 de 3.6 ± 0.9 de 3.3 ± 0.0 d 3.3 ± 0.3 ab

For each concentration, values within a column followed by the same small letters are not significantly different (one-way ANOVA; HSD post-hoc test at p ≤ 0.05). Capital letters along conidial concentration isolate or FAW’s immature stages indicate the statistical difference among the treatments (factorial ANOVA; HSD post-hoc test at p ≤ 0.05).